Monitoring Speaker Program Compliance: Pharma Industry Best Practices

Purchase Option Price
  • Price: $389.00
  • Price: $389.00

Product Description:

AUDIOCONFERENCE ON TAPE OR CD

Sponsored by MSL Compliance Training Workshops

presented on JANUARY 16, 2007

Featuring a behind-the-scenes case study about one company’s new speaker program policy—how they built it and how they plan to monitor the field for adherence!

Situation: Dr. James has  another speaking engagement at your dinner program next month in Chicago. How can you be sure he follows your new policy so we avoid another Dr. Gleason situation? Should we adjust our policy, training or monitoring?

Speaking engagements are valuable tools to help educate providers and KOLs about your product …but as we've seen with the indictment of Dr. Gleason, the prosecutorial and federal spotlight has turned to speaker programs. As former OIG chief Dara Corrigan told us last April, a mistake in speaker compensation or field-level activities could open your compliance program to a broader investigation. That’s the intent.

Solution: Listen to Jane Wright-Mitchell, PharmD, JD, and Daniel Kracov to hear:

    • A case study on how a company has successfully built a new speaker program policy
    • How legal and compliance can work internally with commercial /marketing for compliance with speaker program policies
    • How to handle difficult situations involving compensation, FMV, and day-to-day speaker program issues
Speaking engagements are valuable tools to help educate providers and KOLs about your product .but as we've seen with the indictment of Dr. Gleason, the prosecutorial and federal spotlight has turned to speaker programs. As former OIG chief Dara Corrigan told us last April, a mistake in speaker compensation or field-level activities could open your compliance program to a broader investigation. That's the intent.

Tell a colleague about
this product

ORDER CLASS: U_01-16-2007
SOURCE CODE: EHCM

Related Products